Upgrades:
Starbucks (NASDAQ:SBUX) was upgraded by research analysts at
Argus from a “hold” rating to a “buy” rating in a research note issued to
investors on Monday, MarketBeat.com reports. The brokerage currently has a
$79.00 target price on the coffee company’s stock. Argus’ target price would
suggest a potential upside of 17.19% from the company’s current price. Several
other research analysts have also issued reports on the company. UBS Group
lowered Starbucks from a “hold” rating to a “sell” rating in a research note on
Monday, November 5th. DZ Bank lowered Starbucks to a “sell” rating in a
research note on Monday, November 5th. Mizuho upgraded Starbucks from a
“neutral” rating to a “buy” rating and increased their price objective for the
stock from $56.00 to $75.00 in a research note on Monday, November 5th.
Barclays increased their price objective on Starbucks from $56.00 to $60.00 and
gave the stock an “equal weight” rating in a research note on Friday, November
2nd. Finally, BMO Capital Markets increased their price objective on Starbucks
from $51.00 to $58.00 and gave the stock a “market perform” rating in a
research note on Friday, November 2nd. Three investment analysts have rated the
stock with a sell rating, ten have given a hold rating, eighteen have assigned
a buy rating and one has given a strong buy rating to the company’s stock.
Starbucks currently has a consensus rating of “Buy” and an average price target
of $64.66. Read more …
Realty Income (NYSE:O) was upgraded by Bank of America from
a “neutral” rating to a “buy” rating in a research report issued to clients and
investors on Thursday, Marketbeat Ratings reports. The brokerage presently has
a $72.00 price objective on the real estate investment trust’s stock. Bank of
America’s price objective indicates a potential upside of 14.87% from the
company’s previous close. A number of other analysts also recently issued
reports on the stock. Royal Bank of Canada raised their price objective on
shares of Realty Income from $57.00 to $60.00 and gave the stock a “sector
perform” rating in a report on Tuesday, November 6th. Zacks Investment Research
downgraded shares of Realty Income from a “buy” rating to a “hold” rating in a
report on Wednesday, October 24th. ValuEngine upgraded shares of Realty Income
from a “hold” rating to a “buy” rating in a report on Tuesday, October 23rd.
Morgan Stanley downgraded shares of Realty Income from an “overweight” rating
to an “equal” rating and set a $31.00 price objective for the company. in a
report on Monday, October 1st. Finally, JPMorgan Chase & Co. raised their
price objective on shares of Realty Income from $57.00 to $58.00 and gave the
stock a “neutral” rating in a report on Monday, September 17th. Eight analysts
have rated the stock with a hold rating and seven have given a buy rating to
the stock. Realty Income has an average rating of “Hold” and a consensus target
price of $55.99. Read more …
QUALCOMM (NASDAQ:QCOM) was upgraded by investment analysts
at Morgan Stanley from an “underweight” rating to an “equal weight” rating in a
research note issued to investors on Thursday, The Fly reports. Several other
equities analysts also recently commented on the company. BidaskClub downgraded
QUALCOMM from a “sell” rating to a “strong sell” rating in a research report on
Thursday. Zacks Investment Research raised QUALCOMM from a “hold” rating to a
“strong-buy” rating and set a $63.00 target price on the stock in a research
report on Wednesday. Deutsche Bank decreased their target price on QUALCOMM to
$65.00 and set a “hold” rating on the stock in a research report on Thursday,
November 8th. Stifel Nicolaus decreased their target price on QUALCOMM from
$62.00 to $58.00 and set a “hold” rating on the stock in a research report on
Thursday, November 8th. Finally, Canaccord Genuity decreased their target price
on QUALCOMM from $86.00 to $75.00 and set a “buy” rating on the stock in a
research report on Thursday, November 8th. One research analyst has rated the
stock with a sell rating, ten have assigned a hold rating, twelve have given a
buy rating and one has given a strong buy rating to the company. The company
presently has a consensus rating of “Buy” and an average price target of
$70.44. Read more …
Novartis (NYSE:NVS) was upgraded by investment analysts at
Goldman Sachs Group from a “neutral” rating to a “conviction-buy” rating in a
research report issued to clients and investors on Friday, The Fly reports. Other
analysts have also recently issued reports about the company. BNP Paribas
upgraded Novartis from an “underperform” rating to a “neutral” rating in a
report on Tuesday, September 11th. Barclays upgraded Novartis from an
“underweight” rating to an “equal weight” rating in a report on Thursday, July
19th. Wolfe Research began coverage on Novartis in a report on Tuesday, October
23rd. They issued an “outperform” rating for the company. Exane BNP Paribas
upgraded Novartis from an “underperform” rating to a “neutral” rating in a
report on Tuesday, September 11th. Finally, Zacks Investment Research upgraded
Novartis from a “hold” rating to a “buy” rating and set a $95.00 target price
for the company in a report on Tuesday, September 18th. Eleven research
analysts have rated the stock with a hold rating, five have given a buy rating
and one has issued a strong buy rating to the company. The company currently
has a consensus rating of “Hold” and an average price target of $84.86. Read more …
Taiwan Semiconductor Mfg. (NYSE:TSM) was upgraded by
equities research analysts at Morgan Stanley from an “underweight” rating to an
“equal weight” rating in a research report issued on Friday, The Fly reports. Several
other analysts also recently issued reports on the company. Zacks Investment
Research downgraded Taiwan Semiconductor Mfg. from a “hold” rating to a “sell”
rating in a research note on Thursday, August 23rd. Nomura upgraded Taiwan
Semiconductor Mfg. from a “neutral” rating to a “buy” rating in a research note
on Thursday, July 19th. Finally, ValuEngine downgraded Taiwan Semiconductor
Mfg. from a “buy” rating to a “hold” rating in a research note on Saturday,
August 18th. Four research analysts have rated the stock with a hold rating and
six have issued a buy rating to the company’s stock. Taiwan Semiconductor Mfg.
presently has a consensus rating of “Buy” and a consensus price target of
$46.00. Read more …
Omega Healthcare Investors (NYSE:OHI) was upgraded by stock
analysts at Bank of America from an “underperform” rating to a “neutral” rating
in a research note issued to investors on Friday, The Fly reports. Several
other analysts have also recently issued reports on the company. Stifel
Nicolaus increased their target price on Omega Healthcare Investors from $27.00
to $30.00 and gave the company a “hold” rating in a research report on Tuesday,
August 7th. MED started coverage on Omega Healthcare Investors in a research
report on Tuesday, October 2nd. They issued a “neutral” rating and a $31.00
price objective for the company. They noted that the move was a valuation call.
ValuEngine raised Omega Healthcare Investors from a “sell” rating to a “hold”
rating in a research report on Monday, August 13th. Mitsubishi UFJ Financial
Group reissued a “neutral” rating on shares of Omega Healthcare Investors in a
research report on Tuesday, October 2nd. Finally, Cantor Fitzgerald reissued a
“buy” rating and issued a $34.00 price objective on shares of Omega Healthcare
Investors in a research report on Monday, August 6th. Nine equities research
analysts have rated the stock with a hold rating and two have given a buy
rating to the company’s stock. Omega Healthcare Investors presently has a
consensus rating of “Hold” and an average price target of $31.17. Read more …
Downgrades:
Best Buy (NYSE:BBY) was downgraded by investment analysts at
Bank of America from a “buy” rating to a “neutral” rating in a research note
issued on Tuesday, Marketbeat Ratings reports. They presently have a $70.00
target price on the technology retailer’s stock, down from their previous
target price of $92.00. Bank of America’s price target would indicate a
potential upside of 5.18% from the stock’s previous close. BBY has been the
topic of several other reports. Barclays reaffirmed a “buy” rating and set a
$90.00 price target on shares of Best Buy in a research report on Wednesday,
August 29th. ValuEngine raised shares of Best Buy from a “hold” rating to a
“buy” rating in a research report on Thursday, July 19th. Zacks Investment
Research lowered shares of Best Buy from a “buy” rating to a “hold” rating in a
research report on Friday, July 20th. Credit Suisse Group upped their price
target on shares of Best Buy from $74.00 to $78.00 and gave the stock a “hold”
rating in a research report on Wednesday, August 29th. Finally, Wells Fargo
& Co reaffirmed a “hold” rating and set a $78.00 price target on shares of
Best Buy in a research report on Tuesday, August 28th. Two analysts have rated
the stock with a sell rating, thirteen have issued a hold rating and four have
issued a buy rating to the company’s stock. The stock presently has a consensus
rating of “Hold” and an average target price of $79.25. Read more …
Apple (NASDAQ:AAPL) was downgraded by analysts at Guggenheim
from a “buy” rating to a “neutral” rating in a note issued to investors on
Wednesday, Marketbeat.com reports. A number of other research analysts also
recently commented on the stock. New Street Research downgraded shares of Apple
from a “neutral” rating to a “sell” rating in a research report on Monday,
August 20th. Morgan Stanley lifted their price objective on shares of Apple
from $226.00 to $253.00 and gave the company an “overweight” rating in a
research report on Thursday, November 8th. Bank of America lifted their price
objective on shares of Apple from $250.00 to $256.00 and gave the company a
“buy” rating in a research report on Monday, September 10th. Macquarie set a
$214.00 price objective on shares of Apple and gave the company a “buy” rating
in a research report on Wednesday, August 15th. Finally, Oppenheimer reissued a
“neutral” rating on shares of Apple in a research report on Monday, October
1st. Three investment analysts have rated the stock with a sell rating,
twenty-two have issued a hold rating and twenty-six have assigned a buy rating
to the stock. The stock presently has an average rating of “Hold” and a
consensus target price of $224.12. Read more …
Kellogg (NYSE:K) was downgraded by JPMorgan Chase & Co.
from an “overweight” rating to a “neutral” rating in a note issued to investors
on Wednesday, Marketbeat reports. They presently have a $66.00 price target on
the stock, down from their prior price target of $73.00. JPMorgan Chase &
Co.’s price objective would indicate a potential upside of 5.57% from the
company’s current price. A number of other brokerages have also recently
weighed in on K. Morgan Stanley began coverage on Kellogg in a report on
Monday, September 17th. They issued an “equal weight” rating and a $75.00 target
price on the stock. Wells Fargo & Co reissued a “hold” rating and issued a
$67.00 price objective (up from $62.00) on shares of Kellogg in a research
report on Sunday, August 5th. ValuEngine raised Kellogg from a “hold” rating to
a “buy” rating in a research report on Wednesday, October 24th. Credit Suisse
Group raised their price objective on Kellogg from $71.00 to $75.00 and gave
the company a “hold” rating in a research report on Thursday, August 9th.
Finally, Zacks Investment Research raised Kellogg from a “sell” rating to a
“hold” rating in a research report on Thursday, October 25th. Three analysts
have rated the stock with a sell rating, eleven have assigned a hold rating and
six have given a buy rating to the company’s stock. The company currently has
an average rating of “Hold” and an average price target of $70.22. Read more …
Home Depot (NYSE:HD) was downgraded by analysts at Bank of
America from a “buy” rating to a “neutral” rating in a research report issued
to clients and investors on Friday, The Fly reports. They presently have a
$195.00 price objective on the home improvement retailer’s stock, down from
their previous price objective of $219.00. Bank of America’s price objective
would suggest a potential upside of 9.95% from the company’s previous close. Several
other research firms have also recently commented on HD. Wells Fargo & Co
restated a “buy” rating and set a $230.00 price target on shares of Home Depot
in a research note on Sunday, September 16th. Jefferies Financial Group
initiated coverage on Home Depot in a report on Tuesday, August 21st. They set
a “buy” rating and a $228.00 price objective on the stock. Zacks Investment
Research raised Home Depot from a “hold” rating to a “buy” rating and set a
$228.00 price objective on the stock in a report on Friday, October 5th.
Citigroup upped their price objective on Home Depot from $205.00 to $220.00 and
gave the stock a “positive” rating in a report on Friday, August 10th. Finally,
Piper Jaffray Companies reaffirmed a “hold” rating and set a $203.00 price
objective on shares of Home Depot in a report on Thursday, August 16th. Ten
research analysts have rated the stock with a hold rating and eighteen have
assigned a buy rating to the stock. The company has an average rating of “Buy”
and a consensus target price of $204.16. Read more …
Cardinal Health Inc (NYSE:CAH) – Stock analysts at Leerink
Swann decreased their Q1 2019 earnings per share estimates for Cardinal Health
in a research note issued on Friday, October 12th, Zacks Investment Research
reports. Leerink Swann analyst D. Larsen now expects that the company will post
earnings of $1.10 per share for the quarter, down from their prior estimate of
$1.14. Leerink Swann also issued estimates for Cardinal Health’s FY2019
earnings at $5.10 EPS and FY2020 earnings at $5.50 EPS. CAH has been the
subject of several other reports. Robert W. Baird decreased their target price
on Cardinal Health from $51.00 to $50.00 and set a “neutral” rating for the
company in a research report on Tuesday, August 7th. Argus decreased their
target price on Cardinal Health from $85.00 to $75.00 and set a “buy” rating
for the company in a research report on Monday, July 16th. Royal Bank of Canada
set a $60.00 target price on Cardinal Health and gave the stock a “hold” rating
in a research report on Friday, September 21st. Mizuho reiterated a “hold”
rating and set a $53.00 target price on shares of Cardinal Health in a research
report on Sunday, August 12th. Finally, Zacks Investment Research downgraded
Cardinal Health from a “hold” rating to a “sell” rating in a research report on
Tuesday, October 9th. Four analysts have rated the stock with a sell rating,
seven have issued a hold rating and two have issued a buy rating to the
company. The company currently has a consensus rating of “Hold” and a consensus
target price of $61.33. Read more …
Comments
Post a Comment